facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2019
vol. 106
 
Share:
Share:
abstract:
Case report

Pseudoscleroderma associated with POEMS syndrome

Kalina Wysocka-Dubielecka
1
,
Andrzej Bizoń
1
,
Katarzyna Głogowska
1
,
Dorota Mączyńska-Karcz
1
,
Katarzyna Łoza
1
,
Kazimierz Kalbarczyk
1
,
Oskar Janeczek
2
,
Marek Braszkiewicz
3

  1. Department of Adult Dermatology, Miedzyleski Specialist Hospital, Warsaw, Poland
  2. Department of Neurology, Miêdzyleski Specialist Hospital, Warsaw, Poland
  3. 1st Internal Department, Miêdzyleski Specialist Hospital, Warsaw, Poland
Dermatol Rev/Przegl Dermatol 2019, 106, 529-537
Online publish date: 2019/12/06
View full text Get citation
 
PlumX metrics:
POEMS syndrome is a rare paraneoplastic disorder associated with plasma cell dyscrasia. The acronym stands for coexisting polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes. Other relevant features of the syndrome are papilledema, sclerotic bone lesions, Castleman’s disease, thrombocytosis, weight loss and increased vascular endothelial growth factor levels. The diagnostic criteria for POEMS are as follows: major criteria: polyneuropathy, monoclonal plasma cell dyscrasia; minor criteria: sclerotic bone lesions, Castleman’s disease, organomegaly, endocrinopathies, edemas, skin changes, papilledema. To make a diagnosis, 2 major criteria and 1 minor criterion are required. We present a patient with pseudoscleroderma, polyneuropathy, hypothyroidism, monoclonal gammopathy, edemas and weight loss, who was diagnosed with POEMS syndrome as a result of interdisciplinary cooperation.
keywords:

hypothyroidism, polyneuropathy, monoclonal gammopathy, pseudoscleroderma, POEMS syndrome



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.